Tevogen Bio Holdings Inc. is a biotechnology company focused on developing innovative cell therapies and immunotherapies for the treatment of various diseases, including cancer and viral infections

The company employs advanced technologies to harness the power of the immune system, particularly through the use of genetically modified T cells, with the aim of providing targeted and effective therapeutic solutions. Tevogen is committed to improving patient outcomes by pioneering treatments that address unmet medical needs, while actively engaging in research and development to advance its therapeutic pipeline.